New injectable formulations

摘要

The present invention relates to a new injectable formulation of ramoplanin or a compound of the ramoplanin family. More particularly, the injectable formulations of the invention are particularly suitable for intravenous (i.v.) administration. They contain the active principle(s) in a fat emulsion product for i.v. administration. The formulations of the invention are well tolerated and are effective in particular in severe Gram positive infections.